![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 19, 17023-17031, May 10, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Philipps-Universität Marburg, Fachbereich
Chemie/Biochemie, Hans-Meerwein-Strasse, D-35032 Marburg, Germany
Received for publication, January 4, 2002, and in revised form, February 15, 2002
The acyl carrier proteins (ACPs) of fatty
acid synthase and polyketide synthase as well as peptidyl carrier
proteins (PCPs) of nonribosomal peptide synthetases are modified by
4'-phosphopantetheinyl transferases from inactive
apo-enzymes to their active holo forms by
transferring the 4'-phosphopantetheinyl moiety of coenzyme A to a
conserved serine residue of the carrier protein. 4'-Phosphopantetheinyl transferases have been classified into two types; the AcpS type accepts
ACPs of fatty acid synthase and some ACPs of type II polyketide synthase as substrates, whereas the Sfp type exhibits an
extraordinarily broad substrate specificity. Based on the previously
published co-crystal structure of Bacillus subtilis AcpS
and ACP that provided detailed information about the interacting
residues of the two proteins, we designed a novel hybrid PCP by
replacing the Bacillus brevis TycC3-PCP helix 2 with the
corresponding helix of B. subtilis ACP that contains the
interacting residues. This was performed for the PCP domain as a single
protein as well as for the TycA-PCP domain within the nonribosomal
peptide synthetase module TycA from B. brevis. Both
resulting proteins, designated hybrid PCP (hPCP) and hybrid TycA
(hTycA), were modified in vivo during heterologous expression in Escherichia coli (hPCP, 51%; hTycA, 75%)
and in vitro with AcpS as well as Sfp to 100%. The
designated hTycA module contains two other domains: an adenylation
domain (activating phenylalanine to Phe-AMP and afterward transferring
the Phe to the PCP domain) and an epimerization domain (converting the
PCP-bound L-Phe to D-Phe). We show here that
the modified PCP domain of hTycA communicates with the adenylation
domain and that the co-factor of holo-hPCP is loaded with
Phe. However, communication between the hybrid PCP and the
epimerization domain seems to be disabled. Nevertheless, hTycA is
recognized by the next proline-activating elongation module TycB1
in vitro, and the dipeptide is formed and released as diketopiperazine.
A large number of natural bioactive peptides (e.g.
vancomycin, cyclosporine, tyrocidine, and surfactin) are produced by
bacteria and fungi via a template-directed, nucleic acid-independent
mechanism carried out by multienzyme complexes called nonribosomal
peptide synthetases (NRPSs)1
(1-3). The biosynthetic mechanism of NRPS resembles that of fatty acid
synthases (FASs) and polyketide synthases (PKSs), which catalyze fatty
acids synthesis and production of polyketides like erythromycin and
tetracyclin (4, 5).
NRPSs have a modular architecture; each module is responsible for the
incorporation of one building block into the nascent peptide chain. A
module can be subdivided into domains, each representing the single
enzymatic activity necessary for synthesis and modification of the
peptide chain. The adenylation (A) domain is responsible for substrate
recognition and activation as aminoacyladenylate at the expense of ATP
(6, 7). The downstream PCP domains are the sites of intermediate
binding and serve as carrier units (8). The peptide bond formation
between covalently bound intermediates on two consecutive modules is
catalyzed by a condensation (C) domain (9, 10) (Fig.
1). During this peptide assembly,
optional modifications of the substrates can occur, depending on the
presence of modifying domains within the corresponding module. For
example, epimerization (E) domains catalyze the conversion of
incorporated L-amino acids to their D-isomers
(2).
NRPSs, FASs, and PKSs contain one or more small PCP or ACP domains that
are 80-100 amino acids in length that carry the building blocks and
elongated intermediates to the different catalytic centers. Depending
on the architecture of the multienzyme complex, these carrier proteins
appear as integrated domains or as individual proteins. The PCP domains
in NRPSs and the acyl carrier proteins (ACPs) in FASs and PKSs share a
conserved sequence motif (GX(D/H)S(L/I)(D/K)) containing an
invariable serine residue (11). During posttranslational modification
the 4'-phosphopantetheine (Ppant) co-factor is transferred from
coenzyme A and attached to this serine residue converting the carrier
proteins from the inactive apo form to the active holo form (4) (Fig. 2).
Dedicated 4'-phosphopantetheinyl transferases (PPTases) catalyze the
nucleophilic attack of the hydroxyl side chain of the conserved carrier
protein serine residue onto the 5'-
Recognition of Hybrid Peptidyl Carrier Proteins/Acyl Carrier
Proteins in Nonribosomal Peptide Synthetase Modules by the
4'-Phophopantetheinyl Transferases AcpS and Sfp*
,
, and
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (24K):
[in a new window]
Fig. 1.
Peptide bond formation by NRPS (C-A-PCP)
modules. Reaction 1, the A domain recognizes and
activates a specific amino acid as aminoacyladenylate
(AMP-aa1) at the expense of ATP. Reaction 2, the
aminoacyladenylate (aa1) is then transferred to the 4'-Ppant
of the PCP domain. Reaction 3, the C domain catalyzes the
peptide bond formation between amino acids attached to PCPs of adjacent
modules.
-pyrophosphate linkage of
coenzyme A (CoASH) in a magnesium ion dependent reaction (4).
During peptide or polyketide synthesis, the activated substrates and
elongation intermediates are covalently linked as thioesters to the
thiol moiety of the 4'-Ppant.

View larger version (11K):
[in a new window]
Fig. 2.
Priming reaction of NRPS, PKS, and FAS by
PPTases. PPTase transfer the 4'-phosphopantetheinyl moiety of
coenzyme A to the side chain hydroxyl of a serine residue invariant in
PCPs and ACPs. Thus, the carrier proteins are converted from the
inactive apo form into the active holo
form.
PPTases have been classified into two types based on substrate specificity: the AcpS type of primary metabolism and the Sfp type of secondary metabolism (4, 12). PPTases of the AcpS type are about 120 amino acids in length and have a pI value of about 9.6; they are found in almost every known microorganism and are responsible for the modification of fatty acid ACPs. Biochemical studies demonstrated that ACPs of type II PKS systems, the D-alanyl carrier protein from Lactobacillus casei involved in D-alanylation of lipoteichoic acid (13), and NodF from Rhizobia involved in the acylation of the oligosaccharide-based nodulation factors could be modified by AcpS from Escherichia coli (14), too.
The PPTase Sfp of Bacillus subtilis represents the prototype of the second group of PPTases. Enzymes of this class are about 240 amino acids in length with a pI value of about 6 and have mostly been found associated with NRPS gene clusters (15). The well characterized Sfp exhibits an extraordinarily broad substrate specificity and is able to modify all carrier proteins so far tested including PCPs of NRPSs and ACPs of both FASs and PKSs (16).
The crystal structure of B. subtilis AcpS co-crystallized with CoA and ACP gave detailed insight into the interactions between this enzyme and its substrates (17). It was possible to identify those residues of ACP that are responsible for the protein interaction with AcpS, most of which are provided by helix 3 of the ACP. The solution structure of a prototype PCP domain showed that PCPs fold into a secondary structure similar to that of ACPs (18).
In this study, we present the construction of hybrid PCP/ACP carrier
proteins through the replacement of the coding region for helix 2 in
the TycC3-PCP with the corresponding region of ACP from B. subtilis as well as the replacement of this PCP helix in the
domain of the initiation module TycA of the tyrocidine synthetase. Both
hybrid proteins were biochemically characterized in modification assays
with the PPTases AcpS and Sfp from B. subtilis. Using the
newly created PCP domain within the NRPS module hTycA, we also show
that hPCP is able to perform the necessary communication with the A and
C domains.
| |
EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
General Techniques
E. coli was grown on LB medium with 10 mM MgCl2. The following antibiotics were used: 100 µg/ml ampicillin and 25 µg/ml kanamycin. For E. coli techniques, such as transformation and plasmid preparation, standard protocols were used (19). The HerculaseTM Hotstart polymerase (Stratagene, Heidelberg, Germany) was used to amplify gene fragments for cloning and expression purposes. Oligonucleotides were purchased from MWG Biotech. [3H]CoA and [14C]Phe were purchased from Hartmann Analytics (Braunschweig, Germany).
Construction of Plasmids
Construction of the Plasmid pQE70-hPCP--
The plasmid
pQE70-TycC3-PCP (18) served as a template in a PCR with
oligonucleotides carrying the sequence information for helix 2 (italic)
of ACP from B. subtilis including a SacI
restriction site (underlined) and the sequence from TycC3-PCP
(bold):
5'-ATAGAGCTCGTTATGGAACTTGAAGACGAGTATCAGGTTGAGCTTCC-3' and
5'-ATAGAGCTCAACTACATCTAGGGAATCTCCGCCGATCTGGAAAAAGT-3' to amplify a fragment that contained hPCP, under
control of the T5 promotor of pQE70. This fragment was
treated with SacI, the template DNA was digested with
DpnI, and the PCR product was subsequently religated to
pQE70-hPCP (3664 bp) (Fig. 3).
|
Construction of the Plasmid pQE60-hTycA-- The plasmid pTycA (20) served as a template in a PCR with the following oligonucleotides: 5'-TTTAACTAGTTATGGAACTTGAAGACTATCAATTGAAGCTAGAGACGAAAGAC-3' and 5'-ATATACTAGTTCAACTACATCTAGCGAATCTCCGCCGAGCGAG-3' to amplify a fragment that contained hTycA. This fragment was treated with SpeI, the template DNA was digested with DpnI, and the PCR product was subsequently religated to pQE60-hTycA (6686 bp).
Overproduction and Purification of Recombinant Proteins
E. coli M15, which carries the plasmid pREP4
providing the lacI gene for efficient repression of
transcription, was transformed with the described plasmids. The
proteins were overproduced as previously described (10). Expression was
induced with 1 mM isopropyl-
-D-thiogalactopyranoside (final concentration)
at an A600 of 0.6, and the cells were allowed to
grow for an additional 2 h before being harvested by
centrifugation at 4,500 × g at 4 °C. The cell
pellet was resuspended in buffer A (50 mM Hepes, 150 mM NaCl, pH 7.8) and disrupted by three passages through a cooled French pressure cell. The resulting cell extract was centrifuged at 36,000 × g and 4 °C for 30 min. Protein
purification using Ni2+-nitrilotriacetic acid affinity
chromatography was carried out as previously described. Purified
protein was dialyzed against the respective assay buffer, brought to
10% glycerol (v/v), and stored at
80 °C. TycC3-PCP (hereafter
referred to as PCP), TycA, TycB1, AcpS form B. subtilis, and
Sfp-His6 were produced and purified as previously described
(10). Protein concentrations were determined based on the calculated
extinction coefficient at 280 nm: PCP, 9,530 M
1 cm
1; hPCP, 9,530 M
1 cm
1; and
hTycA-His6, 133,580 M
1
cm
1.
Posttranslational Modification of the Enzymes by Ppant Transferase and CoASH in Vivo
Priming of heterologously expressed proteins was achieved by incubation of 1 µM apo-enzyme with 100 µM CoASH and 25 nM recombinant B. subtilis Ppant transferase Sfp or AcpS for 30 min at 37 °C (16, 21) prior to the addition of any amino acid.
Radioassay for the Detection of Posttranslational Modification of the Enzymes
AcpS and Sfp activity was assayed by using a radioactive assay method essentially as described previously (22). This method measures the incorporation of the 3H-labeled 4'-phosphopantetheine group from [3H]CoA into apo-enzymes. Reaction mixtures containing 75 mM MES/HCl, pH 6.0 (in the case of AcpS 50 mM Tris/HCl, pH 8.8), 10 mM MgCl2, 1 µM of the respective protein, 20 µM CoA, 200 nM [3H]CoA (specific activity, 40 Ci/mmol, 0.95 mCi/ml), and 2.2-5.6 nM AcpS of B. subtilis or 25 nM Sfp were incubated at 37 °C for 30 min. The reactions were stopped by the addition of 0.8 ml of ice-cold 10% trichloracetic acid (w/v) and 15 µl of bovine serum albumin (25 mg/ml). Precipitated protein was collected by centrifugation at 13,000 rpm and 4 °C for 15 min using a microcentrifuge. The pellet was washed twice with 0.8 ml of ice-cold trichloracetic acid (w/v) and resuspended in 180 µl of formic acid. The resulting suspension was mixed with 3.5 ml of Rotiszint Eco Plus scintillation fluid (Roth, Karlsruhe, Germany) and counted using a 1900CA Tri-Carb liquid scintillation analyzer (Packard, Dreieich, Germany).
Kinetic and HPLC Analysis of hPCP and PCP
For kinetic studies, the amount of holo-carrier protein formed was determined by an HPLC method. 800-µl reaction mixtures containing, 1-125 µM apo-PCP or 5-135 µM apo-hPCP, 50 mM Tris/HCl, pH 8.8 (75 mM MES/HCl, pH 6.0, in the case of Sfp) 12.5 mM MgCl2, 2 mM DTT, 1 mM CoA and 11.2 nM AcpS of B. subtilis or 10 nM Sfp were incubated at 37 °C for 10 min. The reaction was stopped, and the protein was precipitated by the addition of 10% trichloracetic acid. The reaction mixtures were centrifuged for 30 min at 13,000 rpm and 4 °C in a microcentrifuge. The pellet was subsequently resuspended in 120 µl of 50 mM Tris/HCl, pH 8.8. A 100-µl sample of this solution was injected onto a reversed phase HPLC column (Nucleosil C18, 250 mm, 5 µm, 300 Å, Macherey and Nagel) equilibrated with 60% solvent A (H2O with 0.1% trifluoroacetic acid) in the case of PCP. apo- and holo-PCP could be separated by applying a 15-ml linear gradient 40-95% solvent B (acetonitrile with 0.1% trifluoroacetic acid) (flow rate, 0.5 ml/min; temperature, 40 °C). The samples were examined for their A220. Under these conditions, the holo-carrier protein migrates faster than the apo form (retention times were 10.67 and 11.95 min, respectively). The amount of holo-PCP formed was determined by comparing the peak area of the holo-PCP formed with those of both apo- and holo-PCP and subtracting the amount of holo-PCP that was already present after the heterologous expression of the protein in E. coli (see "Results"). In the case of hPCP, a 1.2-ml linear gradient to 50% solvent C (methanol with 0.1% trifluoroacetic acid) for 25 min (flow rate, 0.5 ml/min; temperature, 40 °C) followed by a 7.2-ml linear gradient to 90% solvent C at 0.3 ml/min and 40 °C, holo- and apo-hPCP eluted at the respective retention times 26.1 and 27.7 min.
Covalent Incorporation of [3H]Phosphopantetheine into TycA and hTycA
The incorporation of [3H]phosphopantetheine was performed as described previously (22). The reaction mixtures (100 µl) contained 50 mM Tris/HCl, pH 8.8 (in the case of Sfp 75 mM MES/HCl pH 6.0), 10 mM MgCl2, 20 µM CoA, 200 nM [3H]CoA (specific activity, 40 Ci/mmol and 0.95 mCi/ml), 25 nM ACPS or Sfp, and 1 µM apo-TycA or -hTycA. The reactions were started by the addition of the PPTase and were incubated at 37 °C for 30 min. The reactions were quenched with 800 µl of 10% trichloracetic acid (w/v) and 15 µl of 25 mg/ml bovine serum albumin. The mixture was incubated on ice for 15 min. The precipitate was pelleted by centrifugation (13,000 rpm for 30 min in a microcentrifuge), washed twice with 1 ml of 10% trichloracetic acid (w/v), and subsequently solubilized in 180 µl of concentrated formic acid. The redissolved protein was mixed with 3.5 ml of Rotiszint Eco Plus scintillation fluid (Roth), and the amount of radioactivity incorporated was quantified using a 1900CA Tri-Carb liquid scintillation (Packard).
Covalent Incorporation of [14C]Phenylalanine into TycA and hTycA
To investigate the interaction between the A domain and the PCP of TycA and hTycA, both modules were covalently loaded with L- or D-[14C]Phe. Aminoacylation was performed as described previously (10, 23). The synthetases were aminoacylated in reaction mixtures (100 µl) containing assay buffer (75 mM Tris-HCl, pH 8.5, 10 mM MgCl2, 5 mM ATP), 1 µM holo-TycA or holo-hTycA, and 2 µM L-[14C]Phe (450 mCi/mmol) or 2 µM D-[14C]Phe (56 mCi/mmol). The reaction mixtures were incubated at 37 °C for specific times, and samples were taken and quenched with 0.8 ml of ice-cold 10% trichloracetic acid (w/v) and 15 µl of a 25 mg/ml bovine serum albumin. The mixture was incubated on ice for 15 min. The precipitate was pelleted by centrifugation (13,000 rpm for 30 min in a microcentrifuge), washed twice with 1 ml 10% trichloracetic acid (w/v), and solubilized in 180 µl of concentrated formic acid. The redissolved protein was mixed with 3.5 ml of liquid scintillation fluid, and the amount of incorporated radioactivity was quantified by liquid scintillation analysis (Packard).
Radio TLC Assay for Detection of Phe-S-Ppant Epimerization
To investigate the conversion of L-Phe-S-Ppant enzyme to the D-Phe-S-Ppant species (and vice versa), TycA(PheATE) and hTycA(PheATE) were allowed to activate and covalently load L- or D-[14C]Phe (24). Reaction mixtures in assay buffer containing 1 µM holo-enzyme as well as 8.9 µM L-[14C]Phe (450 mCi/mmol) or 71.4 µM D-[14C]Phe (56 mCi/mmol) were incubated for 3 min at 37 °C (final volume, 200 µl). At defined time points, the samples were taken and quenched with 0.8 ml of ice-cold 10% trichloracetic acid (w/v). After 15 min of incubation on ice the precipitate was centrifuged (4 °C, 13,000 rpm, 20 min in a microcentrifuge), and the pellet was washed in succession twice with 1 ml of ice-cold 10% trichloracetic acid, 1 ml of ether/ethanol (3:1 v/v), and 1 ml of ether. The pellet was subsequently dried at 37 °C.
The acid-stable thioester [14C]Phe-S-Ppant was hydrolyzed by incubation with 100 µl of 100 mM potassium hydroxide at 75 °C for 15 min. The extraction of the cleaved amino acid was carried out by the addition of 1 ml of methanol and centrifugation at 4 °C at 13,000 rpm for 30 min in a microcentrifuge. Subsequently, the supernatants containing the released [14C]Phe were transferred to fresh tubes, the solvent was removed under vacuum, and the pellet was dissolved in 10 µl of 50% ethanol (v/v) and applied to chiral TLC plates. The plates were developed in acetonitrile/water/methanol (4:1:1 v/v/v) as solvent. The radioactivity was counted with a two-dimensional radio scanner (Raytest) and quantified using the supplied Radioisotope Thin Layer Analyzer software. The autoradiography was utilized to confirm the integrity of both [14C]Phe substrates. These studies revealed an optical purity of > 99% for L-[14C]Phe and 95% for D-[14C]Phe.
HPLC Analysis for the Detection of Phe-Pro Diketopiperazine (DKP) Formation
The identity of released DKP diastereoisomers was established by HPLC analysis using internal standards. Purified holo-TycA or -hTycA was loaded with either L- or D-Phe and mixed with holo-TycB1 that had been loaded with L-Pro beforehand to assay for dipeptidyl-S-Ppant product formation (25). 200-µl reaction mixtures in assay buffer contained 1 µM enzyme as well as the cognate amino acid (2.5 mM L-Pro and 2.5 mM L- or D-Phe). Simultaneously, 200 µl of each solution were preincubated at 37 °C to ensure a complete aminoacylation of both modules. After 5 min, the condensation reaction was initiated by combining equal volumes of TycA or hTycA and TycB1, and at various time points 50-µl samples were taken and immediately quenched by the addition of 0.45 ml of 10% trichloracetic acid (w/v). The reaction mixtures were extracted with 0.5 ml of butanol/chloroform (4:1 v/v). The organic solvent was transferred to fresh tubes and subsequently removed under vacuum. The pellet was dissolved in 50 µl of 30% methanol and applied to a reversed-phase HPLC column (GROM-SIL120-ODS-4-HE, C18, 60 × 3 mm inner diameter, 5 µm, from GROM, Herrenberg, Germany) equilibrated with 22.5% methanol. D,L and L,L isoforms of Phe-Pro DKP could be separated by isocratic elution using 25% methanol as solvent (temperature, 23 °C; flow rate, 1 ml/min) over 10 min. In the relevant time frame (5.5 and 6.5 min, respectively), the samples were examined for their absorbance at 214 nm.
Circular Dichroism of PCP, hPCP, and ACP
CD spectra were collected with a Jasco J-810
spectropolarimeter in a 0.1-cm water jacketed cell at 25 °C. The
samples were dialyzed against 10 mM sodium phosphate, pH 7. The spectra of the protein (final concentration, 10 µM)
were recorded from 260 to 190 nm in continuous mode with a scanning
speed of 10 nm/min, a time constant of 2 s, and a bandwidth of 1 nm (26). In some experiments the samples were measured and 0.01 volumes
of 1 M MgCl2 were added directly, and the CD
spectrum was remeasured after 30 min of incubation time for the
analysis of the effect of Mg2+ ion on the secondary
structure of carrier proteins. Five spectra of each protein were
measured, and after spectral subtraction of a blank sample,
quantitative deconvolution of CD spectra was performed by computer
using the protein secondary structure estimation program, as described
previously (27).
| |
RESULTS |
|---|
|
|
|---|
Construction of hPCP and hTycA as a New Class of Peptidyl Carrier Proteins-- The motivation behind this study is the construction of a hybrid acyl carrier protein that can be modified in vitro and in vivo by AcpS and Sfp. We have constructed a distinct hPCP through replacement of the region coding for helix 2 in the TycC3-PCP with the corresponding region of ACP (14 amino acids) from B. subtilis as a single domain (Fig. 3). Using the same strategy, we subsequently constructed a hTycA through the replacement of the corresponding helix in the PCP of TycA, the initiation module (comprising three domains: A, PCP, and E) of the tyrocidine synthetase. Both hybrid proteins were constructed on the DNA level using oligonucleotides carrying the genetic information encoding helix 2 of ACP of B. subtilis.
The structure of AcpS from B. subtilis co-crystallized with
CoA and ACP was described previously by Parris et al. (17). It revealed detailed insight into the protein-protein interaction between AcpS and ACP. It was possible to identify those residues of ACP
that are mainly responsible for this interaction. Most of them are
located in helix 2 of ACP (numbering according to Xu et al.
(28)). ACPs and PCPs have a similar function and secondary structure.
The sequence similarity between ACPs and PCPs, however, is very low; it
is concentrated in the immediate neighborhood of the invariant serine
residue (2, 18), whereas the sequence similarity between ACPs of FAS
and PKS is high. The similarity of the loop between helices 1 and 2 and
of the orientation of helix 2 in ACPs is high, whereas sequence
similarity between PCPs can only be found in helix 1 and in the loop
between helix 1 and 2. PCPs were subdivided according to their location
in NRPS modules into two groups: PCPEs upstream of E
domains and PCPCs upstream of C domains (25). The major
differences between PCPs of the two groups are located in the loop
between helix 1 and 2 and in helix 2: 1) the sequence in the
neighborhood of the invariant serine residue of PCPEs is
GGDSIKA(L/I)QXXXRL, whereas for PCPCs it is
GGHSLKA; 2) helix 2 of PCPEs contains three positively
charged amino acids, where PCPCs contain only two, and the
amino acid (Gln) at position 50 in PCPEs is highly
conserved; and 3) PCPEs have a deletion of one amino acid
at position 58 (numbering according to the NMR structure of TycC3-PCP.
This amino acid is localized at the end of helix 2 (Fig.
4).
|
Overproduction and Purification of hPCP, PCP, and hTycA-- Recombinant hPCP, PCP, and hTycA were obtained by heterologous overexpression of the hPCP, PCP, and hTycA genes in E. coli M15 as C-terminal His6 tag fusion proteins and subsequent purification by metal affinity chromatography and gel filtration. SDS-PAGE analysis (data not shown) revealed two bands in the case of hPCP, indicating a significant apo to holo conversion by E. coli AcpS during heterologous expression, just as it was reported for the ACP from B. subtilis and E. coli (21, 29). In the case of PCP and hTycA only one band could be obtained (data not shown). Per liter of cell culture, 20 mg of hPCP (>99% purity), 22 mg of PCP (>98% purity), and 15 mg of hTycA (>85% purity) were obtained.
4'-Ppant Transfer to hPCP and PCP Catalyzed by AcpS and Sfp of B. subtilis-- AcpS type PPTase were reported to be quite intolerant in choosing their substrates (4). AcpS of B. subtilis modified only ACP from FAS and the D-Ala carrier protein from B. subtilis (21). Sfp, on the other hand, has an extraordinarily broad substrate specificity and was able to modify all carrier proteins tested including PCPs of NRPSs and ACPs of both FAS and PKS (16). Additionally, in this study we were able to show that Sfp is able to recognize and modify the hybrid FAS/NRPS carrier protein hPCP.
The conversion of hPCP and PCP from the apo to the
holo form by AcpS and Sfp was determined by a radio assay.
In this assay, the transfer of the [3H]Ppant moiety of
CoA to the strictly conserved serine residue of hPCP and PCP, which is
catalyzed by a PPTase, was detected (Fig. 2). AcpS (25 nM)
and Sfp (25 nM) were incubated with 1 µM apo-hPCP or apo-PCP for 30 min at 37 °C. The
amount of holo-protein formed from the various ACP and PCP
proteins by each PPTase was investigated using a Liquid
Scintillation Counter assay. apo-hPCP was 100%
phosphopantetheinylated by both PPTases, whereas apo-PCP was
converted to 100% holo-PCP only by Sfp. By contrast, AcpS was unable to phosphopantetheinylate native PCP (Fig.
5). These results were verified by
HPLC.
|
Biochemical Characterization of hPCP and PCP--
An HPLC method
was used to determine the catalytic activity of B. subtilis
AcpS and Sfp with both hPCP and TycC3-PCP. The apo to
holo ratios of the purified recombinant proteins were
determined to be 49% to 51% for hPCP and 93% to 7% for PCP,
indicating that PCP was much less phosphopantetheinylated during
expression in E. coli by either endogenous EntD or Yhhu than
was hPCP (4, 8, 30). Reaction mixtures containing 11.2 nM
AcpS of B. subtilis or 10 nM Sfp were incubated
at 37 °C for 10 min. The kinetic constants were determined through a
Michaelis-Menten fit of the data sets, which yielded a
Km of AcpS for hPCP of 21.6 ± 3 µM and a kcat of 14.35 ± 0.5 min
1. The Km of Sfp for hPCP was
determined to be 26 ± 6 µM, and the
kcat was determined to be 96 ± 4 min
1. The Km of Sfp for PCP was
4.45 ± 1 µM, and the kcat was 96 ± 4 min
1 (Table
I). In contrast to the observations made
by Mootz et al. (21), who determined different kinetic
constants for AcpS at low and high apo-ACP concentration,
only one Km and kcat value
could be determined in the case of hPCP.
|
Posttranslational Modification of hTycA with AcpS and Sfp of B. subtilis and Communication of the PCP with the A Domain in hTycA-- A radio assay was applied to determine the catalytic activity of B. subtilis AcpS and Sfp with the parent TycA and hTycA. Reaction mixtures contained 25 nM AcpS or Sfp, and 1 µM of parent TycA or hTycA (apo/holo mixtures as obtained after heterologous expression) were incubated at 37 °C for 30 min. Incubation of parent TycA with either AcpS or Sfp showed that only Sfp was able to modify its PCP domain (Table II; this value was arbitrarily set to 100%), whereas AcpS did not recognize the protein. Purified hTycA (apo/holo mixture) was modified by AcpS and Sfp to 100% holo form with [3H]CoA in vitro. hTycA had been modified to a great extent during heterologous expression; thus only the remaining apo-protein (25%) was radiolabeled during the in vitro experiment (Table II), which is equivalent to a complete conversion to holo-hTycA. To determine the apo to holo ratio of the heterologously expressed hTycA (1 µM, apo/holo mixture), purified hTycA was incubated in the presence of [14C]Phe for 3 min at 37 °C. At defined time points samples were taken, and the bound amino acid was cleaved off by alkaline hydrolysis and applied to chiral TLC plates. The plates were developed, and the proportion of L- to D-Phe was determined using a two-dimensional radio scanner. In the case of hTycA with ATP in the absence of a PPTase, 75% of the protein became aminoacylated with [14C]Phe. Additionally, preincubation of hTycA with AcpS or Sfp in vitro increased the aminoacylation efficiency with [14C]Phe to 100% (Table III). In a control experiment, 5% of the parent TycA (1 µM, apo/holo mixture) with ATP and without PPTase became aminoacylated with [14C]Phe, indicating that the parent TycA was much less phosphopantetheinylated during heterologous expression by either EntD or Yhhu than was hTycA (4, 8, 30). After additional preincubation in vitro with Sfp, the aminoacylation activity increased to 100%. In contrast, AcpS has had no effect in vitro (Table III).
|
|
To resolve the communication between the A and hPCP domains in hTycA, we applied a radio assay. The hTycA and parent TycA were each allowed to covalently bind either L- or D-[14C]Phe. We found that both parent TycA and hTycA were aminoacylated to 100% as Phe-S-Ppant-Enzymes at the first time point measured, so determination of the exact rate constant for this reaction will require rapid quench reaction kinetics (31).
Communication of hPCP Domain with the Epimerization Domain in hTycA-- The natural substrate of the E domain of TycA is the adjacent Phe-S-Ppant-PCP domain (24). To study the communication between the PCP and the E domains in hTycA, the extent of conversion of D- and L-[14C]Phe (and vice versa) catalyzed by the E domain was investigated. Although the DNA sequence of hTycA was correct, this protein was not able to convert D- or L-[14C]Phe, indicating a disturbed PCP-E communication. As a control experiment, parent TycA was utilized. As described previously, the equilibrium position of ~70% D-Phe-S-Ppant was reached within 30s (25).
Communication of hTycA with TycB1 and DKP Formation
Assay--
TycB1, the first module of the tyrocidine synthetase B,
being the natural substrate of TycA (23), was used to explore the intermodule communication of hTycA with the C domain of another NRPS
module. Prior studies reported that only D-Phe is
transferred from TycA to TycB1, forming the
D-Phe-L-Pro (10). HPLC was used for the
identification of noncatalytically released DKP. The
holo-hTycA was incubated with D-Phe or
L-Phe, holo-TycB1, L-Pro, and ATP. No product could be detected in the case of holo-hTycA with
L-Phe as substrate, whereas parent TycA, under the same
conditions, was able to transfer D-Phe to TycB1, resulting
in DKP formation. However, when holo-hTycA was incubated
with D-Phe instead of L-Phe, DKP could be
detected (25% of parent TycA). This result supports the finding that
hTycA cannot convert L-Phe to D-Phe, which
would be required for DKP formation. Additionally, utilizing an S562A mutant of TycA in the same assay did not result in the formation of any
DKP with either L- or D-Phe. The rate of DKP
formation under the reaction condition of parent TycA with
L-Phe was 45 ± 1.1 min
1 and that with
D-Phe was 56 ± 1.3 min
1, whereas in the
case of hTycA it was 14 ± 0.7 min
1 with
D-Phe as substrate (Table
IV). The decreased rate of the latter
indicates an impaired communication of hTycA with the C domain of
TycB1.
|
Secondary Structure Analysis of hPCP, PCP, and ACP with CD--
CD
was used to assess the impact of the swap of 14 amino acids on the
secondary structure of the engineered carrier protein hPCP. The CD
spectrum of B. brevis TycC3-PCP in sodium phosphate buffer
at pH 7 was consistent with the previously reported NMR structure,
indicating an
-helix content of 46-48%. The CD spectrum of
B. subtilis ACP of fatty acid synthase and hPCP showed
45-48% and 45-50%
-helix content, respectively (Fig.
6). This result indicates that
the secondary structure of hPCP is similar to PCP and ACP (18,
28).
|
Analysis of Mg2+-containing samples indicated that the
secondary structures of ACP, PCP, and hPCP are unaffected by the
presence of this cation. Surprisingly, we found that the
-helix
content of the PCP, hPCP, and ACP seemed to increase at lower protein concentrations (2 µM) to 80, 75, and 79%, respectively.
| |
DISCUSSION |
|---|
|
|
|---|
For the NRPS, PKS, and FAS multienzyme complexes to become functionally active, the embedded PCPs and ACPs need to be primed with the 4'-Ppant co-factor moiety of CoA by the dedicated PPTase. The PPTases of the AcpS type have, in contrast to the Sfp type PPTases, a narrow substrate specificity and are only able to modify ACPs of FAS and type II PKS, whereas they show absolutely no activity toward PCPs of NRPSs. We present in this work the construction of the first hybrid PCP/ACP protein that can be modified by AcpS and Sfp in vitro and in vivo.
From the co-crystal structure of B. subtilis AcpS with its
natural substrate ACP, detailed insight into the amino acid residues involved in the interaction of the two proteins was obtained (17). The
interaction at the interface between the basic AcpS and the acidic ACP
is primarily hydrophilic in nature. This interface consists mostly of
helix
1 of AcpS and helix
3 of ACP. Zhang et al. (32)
have recently identified the ACP docking site on
-ketoacyl-ACP
synthase III (FabH) (both E. coli proteins) using computational analysis that was later verified by site-directed mutagenesis. Again, most residues of ACP involved in the interaction can be found in helix
2. This knowledge raised the question of whether the residues in helix 2 of acyl and peptidyl carrier proteins may represent the determinants that other proteins such as AcpS and Sfp
use to distinguish them, prompting us to carry out a careful comparison
of the different acyl carrier protein species.
The NMR solution structures of E. coli and B. subtilis FAS-ACP, Streptomyces coelicolor actinorhodin
PKS-ACP, and B. brevis TycC3-PCP show no significant
differences in the overall structure, a four-helix bundle. Members of
this superfamily are characterized primarily by two structural motifs;
helix 1 is in anti-parallel orientation and helix 4 is in parallel
orientation to helix 2, whereas the orientation and length of helices
1, 3, and 4 vary. The most obvious difference between ACPs and PCPs is
the electrostatic surface potential, especially around the invariant
serine residue and adjacent helix (2). The second noticeable difference
is the overall pI value; B. subtilis FAS-ACP, TycC3-PCP, and
the hPCP designed in this study have pI values of 3.8, 7.6, and 4.9, respectively (Fig. 7). The corresponding
PPTases, AcpS of primary metabolism and Sfp of secondary metabolism,
have pI values of 9.6 and of 5.6, respectively. How is the interaction
of the carrier protein with the corresponding PPTase mediated? The
co-crystal structure has shown that the carrier protein part of the
interface consists mostly of helix 2 of ACPs (numbering according to Xu et al. (28)) or, if this can be generalized, of the
corresponding region (helix 2) of PCPs (numbering according to the NMR
structure of TycC3-PCP (18)). In addition, sequence alignments (Fig. 4) have shown that this very helix is a consistent structural element within the different subfamilies (ACPs or PCPCs or
PCPEs) but differs significantly between species. Hence,
the choice of one carrier protein over another as substrate by a
certain PPTase is probably determined by differences in charge and
hydrophobic nature of these helices. Additionally, the overall charge
of the whole carrier protein as well as steric reasons may also play a
role in protein-protein recognition. The replacement of the amino acid
making up helix 2 in the TycC3-PCP with the corresponding region of ACP
from B. subtilis for the single PCP domain as well as for
the PCP domain of the initiation module TycA demonstrates that the
exchange of 14 amino acids in PCP and 12 amino acids in TycA allows
these proteins still to be recognized by Sfp and, for the first time,
by AcpS as well. The kinetic studies with Sfp indicated that the
kcat/Km for hPCP lies between that for PCP and ACP, corresponding to a 6-fold drop compared with PCP
and a 12-fold increase in catalytic efficiency compared with ACP. The
kcat values of Sfp for hPCP and PCP are the
same, whereas the kcat value for ACP is about
eight times lower compared with that for hPCP. Based on these findings,
we propose that the hPCP is more closely related to PCP than to ACP, as
expected, because about 84% of its amino acids derive from PCP. In
addition, hPCP seems to be a more suitable substrate for Sfp than is
ACP. In agreement with this hypothesis, we found only one
Km and kcat value for the
substrate hPCP, whereas Mootz et al. (21) determined two
Km and kcat values of Sfp as
well as AcpS for the substrate apo-ACP at low (2-8
µM) and higher (20-200 µM) concentrations.
Interestingly, the Km of AcpS for the modification
of hPCP is three times lower than the Km for ACP.
The kcat for hPCP, on the other hand, is about
10 times lower than that for ACP. Thus, the catalytic efficiency of
AcpS with hPCP is diminished by a factor of three compared with the natural substrate ACP. The simple interpretation of this data suggests
that although AcpS is now capable of recognizing the new protein, the
catalytic efficiency is low so that the hPCP would not be a
good replacement of a PCP or an ACP. Despite the fact that Mootz
et al. (21) determined the catalytic efficiency of Sfp with
ACP to be even lower (Table I), they were able to construct B. subtilis HM0489 that contains Sfp as the sole PPTase. The
phenotype of this strain is that of the wild type, so Sfp seems to be
competent enough to serve both primary (FAS) and secondary (NRPS)
metabolism. In light of these results, we propose that hPCP is close to
a universal carrier protein as far as PPTases are concerned.
|
The CD spectra of PCP, ACP, and hPCP at pH 7 showed that all three
proteins have a similar secondary structure. Interestingly, the
-helix content of the proteins is
concentration-dependent. The acyl carrier proteins probably
undergo a conformational change as their concentration increases, which
may partially explain why two Km and
kcat values could be determined for the ACPs of
B. subtilis and Streptococcus pneumoniae at high
and low concentrations (21, 33).
The crystal structures revealed that AcpS functions as a trimer (17, 33), whereas Sfp acts as a monomer (12, 16). Comparison of the two protein structures has shown that the active site of Sfp is shallower and wider than that of AcpS. It was argued that this is in accord with the size of their natural substrates, because ACP is a small distinct acidic protein in contrast to the large NRPS modules with neutral PCPs. The PCPs of NRPS modules seem to fit nicely into the shallow Sfp active site but not into the narrow AcpS active site. In this work, we were able to show that both hPCP and hTycA were modified in vivo by E. coli AcpS during heterologous expression (hPCP, 51%; hTycA, 70%) and in vitro by AcpS of B. subtilis as well as Sfp to 100%, whereas the corresponding parent proteins TycC3PCP and TycA were modified to 7 and 6%, respectively. The percentage of modification was increased at prolonged induction times; when hTycA was expressed for 3 h instead of 2 h, more than 85% of the protein present was holo-hTycA. These observations illustrate nicely that the polarity of the active site is more important for the determination of substrate specificity than structural considerations.
Recently, Linne et al. (25) reported the biochemical investigation of a set of hybrid proteins with domain fusions between A and PCP domains as well as PCP and E domains. They described that epimerization activity was only observed in the case of fusion proteins where the PCP domain originated from modules containing an E domain (PCPE). Moreover, analysis of sequence alignments revealed that the differences between PCPCs compared with PCPEs are localized within helices 2 and 3 of PCPs. They suggested that this region is important for a proper interaction of PCP and E domains. Our data strongly support this proposal. We were able to investigate the communication between the PCP and two other domains of hTycA, the A and E domains. Kinetic studies of the aminoacylation reaction of hTycA and parent TycA showed that the A domain does not differentiate very strictly between PCP substrates. The PCP domain has a much greater influence in the case of the epimerization reaction of hTycA, however, because the E domain was not capable of converting covalently bound Phe from the L- to D-isomer. The communication between the hPCP and E domains is disabled because of the swap of 12 amino acids in the PCP domain of hTycA.
TycB1-CAT, the first module of TycB and natural substrate of TycA, was used to explore the intermodule communication of hTycA with another NRPS module. The aminoacylated D-Phe-hTycA was able to transfer its amino acid onto aminoacylated L-Pro-TycB1-CAT, and the product D-Phe-L-Pro-DKP was formed but with a significant lower rate than with the parent TycA. Prior studies reported that the incubation of an epimerization domain deletion mutant of GrsA (PheAT), the first module of the gramicidin synthetase from B. brevis, with TycB1-CAT did not result in formation of DKP (10). In contrast, the inactivation of the E domain by point mutations resulted in product formation activity only if D-Phe was used as substrate. These results suggested that the E domain is necessary for the recognition by the C domain of TycB1-CAT and that the C domain is specific for D-Phe. In the case of hTycA, however, the intact epimerization domain still exists, but communication with TycB1-CAT was nevertheless impaired. In the light of these results it seems plausible that the intermodule communication is established by a combination of PCP and E domain rather than by the E domain alone.
The main goal of this study was to determine the region of ACPs or PCPs
that is recognized by PPTases of the AcpS and Sfp types. Additionally,
our data present the first recombinant NRPS system containing a
designed PCP domain that does not require a dedicated NRPS-PPTase but
is efficiently primed by the E. coli PPTase AcpS. It has
frequently been necessary to co-express Sfp when expressing NRPSs
heterologously in E. coli to ensure complete apo
to holo conversion. Using this new hybrid approach, it would now be possible (in some cases) to obtain fully phosphopantetheinylated NRPSs independent of the host used for expression.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Thomas Weber for providing plasmid pQE70-TycC3-PCP and Dirk Schwarzer and Uwe Linne for discussions and critical comments on the manuscript. We thank Henning Mootz for providing plasmid pTycA and Antje Schäfer for excellent technical assistance.
| |
FOOTNOTES |
|---|
* This work was supported by the Deutsche Forschungsgemeinschaft and Fonds der Chemischen Industrie.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
These authors contributed equally to this work.
§ To whom correspondence should be addressed. Tel.: 49-6421-2825722; Fax: 49-6421-2822191; E-mail: Marahiel@chemie.uni- marburg.de.
Published, JBC Papers in Press, February 26, 2002, DOI 10.1074/jbc.M200120200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: NRPS, nonribosomal peptide synthetase; ACP, acyl carrier protein; FAS, fatty acid synthase; PCP, peptidyl carrier protein; PKS, polyketide synthase; Ppant, 4'-phosphopantetheine; PPTase, 4'-phosphopantetheine transferase; A, adenylation; C, condensation; E, epimerization; HPLC, high pressure liquid chromatography; DKP, diketopiperazine; CoASH, coenzyme A (where SH represents the free thiol group present in this co-factor).
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Stachelhaus, T., Mootz, H. D., and Marahiel, M. A. (2002) in Nonribosomal Assembly of Peptide Antibiotics on Modular Protein Templates (Sonenshein, A. L., ed) , pp. 415-435, ASM Press, Washington D.C. |
| 2. |
Marahiel, M. A.,
Stachelhaus, T.,
and Mootz, H. D.
(1997)
Chem. Rev.
97,
2651-2673[CrossRef][Medline]
[Order article via Infotrieve] |
| 3. |
Stein, T.,
Vater, J.,
Kruft, V.,
Otto, A.,
Wittmann-Liebold, B.,
Franke, P.,
Panico, M.,
McDowell, R.,
and Morris, H. R.
(1996)
J. Biol. Chem.
271,
15428-15435 |
| 4. |
Lambalot, R. H.,
Gehring, A. M.,
Flugel, R. S.,
Zuber, P.,
LaCelle, M.,
Marahiel, M. A.,
Reid, R.,
Khosla, C.,
and Walsh, C. T.
(1996)
Chem. Biol.
3,
923-936[CrossRef][Medline]
[Order article via Infotrieve] |
| 5. |
Walsh, C. T.,
Gehring, A. M.,
Weinreb, P. H.,
Quadri, L. E.,
and Flugel, R. S.
(1997)
Curr. Opin. Chem. Biol.
1,
309-315[CrossRef][Medline]
[Order article via Infotrieve] |
| 6. |
Turgay, K.,
Krause, M.,
and Marahiel, M. A.
(1992)
Mol. Microbiol.
6,
2743-2744[CrossRef][Medline]
[Order article via Infotrieve] |
| 7. |
Stachelhaus, T.,
and Marahiel, M. A.
(1995)
J. Biol. Chem.
270,
6163-6169 |
| 8. |
Stachelhaus, T.,
Huser, A.,
and Marahiel, M. A.
(1996)
Chem. Biol.
3,
913-921[CrossRef][Medline]
[Order article via Infotrieve] |
| 9. |
Schwarzer, D.,
and Marahiel, M. A.
(2001)
Naturwissenschaften
88,
93-101[CrossRef][Medline]
[Order article via Infotrieve] |
| 10. |
Stachelhaus, T.,
Mootz, H. D.,
Bergendahl, V.,
and Marahiel, M. A.
(1998)
J. Biol. Chem.
273,
22773-22781 |
| 11. |
De Crecy-Lagard, V.,
Marliere, P.,
and Saurin, W.
(1995)
C. R. Acad. Sci. III
318,
927-936[Medline]
[Order article via Infotrieve] |
| 12. |
Reuter, K.,
Mofid, M. R.,
Marahiel, M. A.,
and Ficner, R.
(1999)
EMBO J.
18,
6823-6831[CrossRef][Medline]
[Order article via Infotrieve] |
| 13. |
Debabov, D. V.,
Heaton, M. P.,
Zhang, Q.,
Stewart, K. D.,
Lambalot, R. H.,
and Neuhaus, F. C.
(1996)
J. Bacteriol.
178,
3869-3876 |
| 14. |
Ritsema, T.,
Geiger, O.,
van Dillewijn, P.,
Lugtenberg, B. J. J.,
and Spaink, H. P.
(1994)
J. Bacteriol.
176,
7740-7743 |
| 15. |
Nakano, M. M.,
Corbell, N.,
Besson, J.,
and Zuber, P.
(1992)
Mol. Gen. Genet.
232,
313-321[Medline]
[Order article via Infotrieve] |
| 16. |
Mofid, M. R.,
Marahiel, M. A.,
Ficner, R.,
and Reuter, K.
(1999)
Acta Crystallogr. D Biol. Crystallogr.
55,
1098-1100[CrossRef][Medline]
[Order article via Infotrieve] |
| 17. |
Parris, K. D.,
Lin, L.,
Tam, A.,
Mathew, R.,
Hixon, J.,
Stahl, M.,
Fritz, C. C.,
Seehra, J.,
and Somers, W. S.
(2000)
Structure Fold Des.
8,
883-895[Medline]
[Order article via Infotrieve] |
| 18. |
Weber, T.,
Baumgartner, R.,
Renner, C.,
Marahiel, M. A.,
and Holak, T. A.
(2000)
Structure Fold Des.
8,
407-418[Medline]
[Order article via Infotrieve] |
| 19. | Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY |
| 20. |
Mootz, H. D.,
Schwarzer, D.,
and Marahiel, M. A.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
5848-5853 |
| 21. |
Mootz, H. D.,
Finking, R.,
and Marahiel, M. A.
(2001)
J. Biol. Chem.
276,
37289-37298 |
| 22. |
Quadri, L. E.,
Weinreb, P. H.,
Lei, M.,
Nakano, M. M.,
Zuber, P.,
and Walsh, C. T.
(1998)
Biochemistry
37,
1585-1595[CrossRef][Medline]
[Order article via Infotrieve] |
| 23. |
Mootz, H. D.,
and Marahiel, M. A.
(1997)
J. Bacteriol.1
179,
6843-6850 |
| 24. |
Stachelhaus, T.,
and Walsh, C. T.
(2000)
Biochemistry
39,
5775-5787[CrossRef][Medline]
[Order article via Infotrieve] |
| 25. |
Linne, U.,
Doekel, S.,
and Marahiel, M. A.
(2001)
Biochemistry
40,
15824-15834[CrossRef][Medline]
[Order article via Infotrieve] |
| 26. |
Flaman, A. S.,
Chen, J. M.,
Van Iderstine, S. C.,
and Byers, D. M.
(2001)
J. Biol. Chem.
276,
35934-35939 |
| 27. | Yang, J. T. (1986) Enzymology 130, 208-269 |
| 28. |
Xu, G. Y.,
Tam, A.,
Lin, L.,
Hixon, J.,
Fritz, C. C.,
and Powers, R.
(2001)
Structure
9,
277-287[Medline]
[Order article via Infotrieve] |
| 29. |
Lambalot, R. H.,
and Walsh, C. T.
(1995)
J. Biol. Chem.
270,
24658-24661 |
| 30. |
Flugel, R. S.,
Hwangbo, Y.,
Lambalot, R. H.,
Cronan, J. E., Jr.,
and Walsh, C. T.
(2000)
J. Biol. Chem.
275,
959-968 |
| 31. |
Luo, L.,
and Walsh, C. T.
(2001)
Biochemistry
40,
5329-5337[CrossRef][Medline]
[Order article via Infotrieve] |
| 32. |
Zhang, Y. M.,
Rao, M. S.,
Heath, R. J.,
Price, A. C.,
Olson, A. J.,
Rock, C. O.,
and White, S. W.
(2001)
J. Biol. Chem.
276,
8231-8238 |
| 33. |
McAllister, K. A.,
Peery, R. B.,
Meier, T. I.,
Fischl, A. S.,
and Zhao, G.
(2000)
J. Biol. Chem.
275,
30864-30872 |